share_log

Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying

Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying

斯凱生物科學和另外兩隻細價股內部人士正在買入
Benzinga ·  02/05 22:30

The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五收盤上漲超過100點。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲了解更多,請查看 本辛加的內幕交易 平台。

Skye Bioscience

斯凱生物科學

  • The Trade: Skye Bioscience, Inc. (OTC:SKYE) 10% owner Scott M Rocklage acquired a total of 5,206,074 shares an average price of $2.31. To acquire these shares, it cost around $12,026,031.
  • What's Happening: Piper Sandler analyst Edward Tenthoff initiated coverage on Skye Bioscience with an Overweight rating and announced a price target of $12.
  • What Skye Bioscience Does: Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases.
  • 交易:斯凱生物科學公司(場外交易代碼:SKYE)10% 的所有者 Scott M Rocklage 共收購了5,206,074股股票 平均價格爲2.31美元。收購這些股票的成本約爲12,026,031美元。
  • 發生了什麼:派珀·桑德勒分析師愛德華·滕索夫以增持評級啓動了對斯凱生物科學的報道,並宣佈目標股價爲12美元。
  • Skye Bioscience的所作所爲:臨床階段的製藥公司Skye Bioscience, Inc. 發現、開發和商業化用於治療傳染病的大麻素分子。

New Peoples Bankshares

新人民銀行股票

  • The Trade: New Peoples Bankshares, Inc. (OTC:NWPP) Director
  • Blaine Scott White acquired a total of 89,557 shares at at an average price of $2.50. To acquire these shares, it cost around $223,893.
  • What's Happening: The company's stock gained around 11% over the past six months.
  • What New Peoples Bankshares Does: New Peoples Bankshares Inc is a bank holding company for New Peoples Bank.
  • 貿易:新人民銀行股份有限公司(場外交易代碼:NWPP)董事
  • 布萊恩·斯科特·懷特 共收購了89,557股股票 平均價格爲2.50美元。收購這些股票的成本約爲223,893美元。
  • 發生了什麼:該公司的股票在過去六個月中上漲了約11%。
  • 新人民銀行的所作所爲:新人民銀行股份公司是新人民銀行的銀行控股公司。

Check This Out: How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q4 Earnings Report

看看這個: 在第四季度業績發佈之前,如何從禮來股票中每月賺取500美元

Vivani Medical

維瓦尼醫療

  • The Trade: Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired a total of 100 shares at an average price of $1.01. The insider spent around $101.00 to buy those shares.
  • What's Happening: Vivani Medical, during November, posted a wider-than-expected quarterly loss.
  • What Vivani Medical Does: Vivani Medical Inc is a preclinical stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases.
  • 交易:Vivani Medical, Inc.(納斯達克股票代碼:VANI)董事格雷格·威廉姆斯 共收購了 100 股股票 平均價格爲1.01美元。知情人士花費了約101.00美元購買了這些股票。
  • 發生了什麼:Vivani Medical在11月公佈的季度虧損超出預期。
  • Vivani Medical做什麼:Vivani Medical Inc是一家臨床前階段的生物製藥公司。它利用其專有的NanoPortal技術開發微型皮下植入物,以長期、近乎恒定的速率輸送各種治療慢性病的藥物。


Don't forget to check out our premarket coverage here


別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論